The global regenerative medicine market value is expected to reach US$ 23.7 Billion by the end of 2027, decelerating at a CAGR of 16.1% from 2020 to 2027. The report contains 150+ pages with detailed analysis. The study provides the overall revenue of the global regenerative medicine market from 2016 to 2027, considering 2020 as the base year and 2027 as the forecast year.
The global regenerative medicine market research report gives a brief summary of definitions, size analysis, and place of production, sales, applications, types, and major players/key vendors of the regenerative medicine industry. The report presents fresh perspectives on opportunities and challenges in a significantly transformed post-COVID-19 marketplace. This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers a competitive scenario that comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.
Regenerative medicine is the division of medicine that promotes methods to repair, regrow or replace injured or diseased tissues, organs or cells. Regenerative medicine comprises of the formation and use of remedial stem cells, manufacturing of artificial organs, and tissue engineering. The combinations of tissue engineering, cell and gene therapies can strengthen the natural healing procedure in the places it is desired most, or occupy the role of a permanently injured organ. Regenerative medicine is a rather new field that connects experts in chemistry, biology, engineering, computer science, robotics, medicine, genetics and other domains to find explanations to some of the most interesting medical problems confronted by humankind.
Get the Sample Pages of Report for More Understanding@ https://www.precedenceresearch.com/sample/1176
Factors such as increasing prevalence of chronic disorders and genetic disorders, increasing popularity of stem cells, increasing number of trauma emergencies is driving the growth of regenerative medicine market. An illness or disorder that usually persists for 3 months or longer and might get worse over a period is termed as chronic disorder. Chronic diseases mostly occur in the elderly people and can typically be controlled but not repaired. The most prevalent types of chronic ailments are heart disease, arthritis, cancer, diabetes, and stroke. Cardiovascular disorders are the biggest cause of deaths worldwide. As per the WHO data, deaths due to cardiovascular disorders represent almost 31% of the deaths globally.
Almost 85% of these demises are due to stroke and heart attack. Diabetes is another most prevalent chronic ailment that affects millions of people globally. According to International Diabetes Federation (IDF), around 463 million adults (age group: 20-79 years) are battling with diabetes and by the year 2045 the number will rise to a staggering 700 million. Furthermore, approximately 75% of all health care expenses are owed to chronic ailments. Four out of the five most costly health conditions are chronic disorders such as cancer, heart disease, pulmonary conditions, and mental disorders. Regenerative medicine approaches such as stem cell therapy can cure the chronic ailments such as diabetes and arthritis, which otherwise require lifetime of medications.
The role of regenerative medicine in post trauma recovery is constantly evolving as more and more research is showing positive results. The use of regenerative medicine can be a landmark moment in the history of healthcare that will transform the treatment of chronic ailments and trauma related conditions. Thus, the high incidence of chronic ailments is driving the growth of regenerative medicine market.
- Among the product segment, tissue-engineering is expected to dominate the overall market. Tissue engineering has advanced from the field of biomaterials growth and refers to the exercise of uniting cells, scaffolds, and biologically dynamic molecules into efficient tissues. The aim of tissue engineering is to accumulate functional constructs that reinstate, sustain, or progress damaged tissues or complete organs. Progenitor and stem cell therapies are expected to advance at a significant CAGR in the estimate timeframe majorly due to constantly increasing applications.
- The musculoskeletal division accounted for the largest revenue in the application segment with more than 31% share in 2019. High incidence of musculoskeletal disorders such as rheumatoid arthritis, osteoarthritis, tendinitis, and fibromyalgia is the major reason for high market share of musculoskeletal division.
- Integra Life Sciences Corporation accounted for a significant share of the global regenerative medicine market.
The report covers data for North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. In 2019, North America dominated the global market with a market share of more than 45%. U.S. represented the highest share in the North American region primarily due to constant activity in the field of drug discovery and tissue engineering. Moreover, early adoption of latest healthcare technologies also contributed to the high market share of the United States.
Europe was the second important market chiefly due to favorable reimbursement scenario and presence of latest healthcare infrastructure. The presence of skilled researchers in the European region is also expected to boost the demand for regenerative medicine market in the near future. Asia Pacific is anticipated to grow at the maximum CAGR of around18% in the forecast period due to high incidence of trauma cases and chronic disorders. Latin America and the African and Middle Eastern region will display noticeable growth.
Top Players Contending in the Market:
The key companies are aiming towards advanced innovations and are predictable to dominate the target market. Foremost players inspiring in the global regenerative medicine market are as follows:
- Integra LifeSciences Corporation
- Aspect Biosystems
- Amgen, Inc.
- Medtronic plc
- Novartis AG
- Smith & Nephew plc
- MiMedx Group
- Shenzhen SibionoGeneTech Co., Ltd.
- Gene Therapies
- Cell Therapies
- Progenitor and Stem Cell Therapies
- Wound Care
- North America (U.S. and Canada)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Some of the key highlights covered in the report include:
Market Demand-Supply Analysis – The report covers detailed insights into demand and supply forces prevailing in the global regenerative medicine market. It examines trends and factors influencing demand for regenerative medicine globally and gauges the impact of the same on the production.
Pricing Analysis – The report presents an exclusive pricing analysis. It compares pricing strategies adopted by the leading market players and identifies the most remunerative strategies.
Market Segmentation – The report segments the global market in terms of diverse criteria. It identifies the leading segment within each category and identifies growth drivers and restraints affecting growth across each segment.
Regional Analysis – The report segments the market in terms of North America, Europe, Latin America, Asia Pacific, and Rest of the World in terms of region. It has chapters exclusively dedicated to analyzing growth trends across each region. It identifies growth drivers as well challenges affecting demand for regenerative medicine across the world.
Competitive Analysis – Some of the leading market players are profiled in the report on regenerative medicine. The report offers an estimation of share individually help by the market players and determines the impact of some of their popular strategies.
COVID-19 Impact Analysis – This chapter is exclusively dedicated to gauging how the market has evolved or will develop in the post-pandemic era.
Growth Recommendations – In the end, the report presents valuable recommendations to ready businesses for unforeseen challenges in the near future.
Why should you invest in this report?
If you are aiming to enter the global regenerative medicine market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for regenerative medicine are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2020-2027 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
Chapter 2. Research Methodology
2.1. Research Approach
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Regenerative Medicine Market Variables and Scope
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on Regenerative Medicine Market
5.1. Covid-19: Regenerative Medicine Industry Impact
5.2. Regenerative Medicine Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Regenerative Medicine Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Regenerative Medicine Market Players to deal with Covid-19 Pandemic Scenario
Chapter 6. Regenerative Medicine Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
184.108.40.206. Increasing prevalence of chronic ailments
220.127.116.11. Growing incidence of genetic disorders
6.1.2. Market Restraints
18.104.22.168. High cost of treatment
22.214.171.124. Lack of skilled manpower
6.1.3. Market Opportunities
126.96.36.199. Increasing investment in research and development
188.8.131.52. Strong product pipeline
Chapter 7. Global Regenerative Medicine Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
184.108.40.206. Regenerative Medicine Market Revenue by Market Players (2016 -2019)
220.127.116.11. Regenerative Medicine Market Revenue Market Share by Market Players (2016 -2019)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
18.104.22.168. Product Portfolio Expansion, Geographic Expansion, Product Innovation
22.214.171.124. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
126.96.36.199. List of Suppliers
188.8.131.52. List of End-users
Chapter 8. Global Regenerative Medicine Market, By Product
8.1. Regenerative Medicine Market, by Product, 2016-2027
8.1.1. Gene Therapies
184.108.40.206. Market Revenue and Forecast (2016-2027)
8.1.2. Cell Therapies
220.127.116.11. Market Revenue and Forecast (2016-2027)
18.104.22.168. Market Revenue and Forecast (2016-2027)
8.1.4. Progenitor and Stem Cell Therapies
22.214.171.124. Market Revenue and Forecast (2016-2027)
126.96.36.199. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Regenerative Medicine Market, By Application
9.1. Regenerative Medicine Market, by Application, 2016-2027
9.1.1. Wound Care
188.8.131.52. Market Revenue and Forecast (2016-2027)
184.108.40.206. Market Revenue and Forecast (2016-2027)
220.127.116.11. Market Revenue and Forecast (2016-2027)
18.104.22.168. Market Revenue and Forecast (2016-2027)
22.214.171.124. Market Revenue and Forecast (2016-2027)
126.96.36.199. Market Revenue and Forecast (2016-2027)
Chapter 10. Global Regenerative Medicine Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue Forecast by Product(2016-2027)
10.1.2. Market Revenue Forecast by Application(2016-2027)
10.1.3.1. Market Revenue Forecast (2016-2027)
10.1.4.1. Market Revenue Forecast (2016-2027)
10.2.1. Market Revenue Forecast by Product (2016-2027)
10.2.2. Market Revenue Forecast by Application (2016-2027)
10.2.3.1. Market Revenue Forecast (2016-2027)
10.2.4.1. Market Revenue Forecast (2016-2027)
10.2.5.1. Market Revenue Forecast (2016-2027)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2016-2027)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Product (2016-2027)
10.3.2. Market Revenue Forecast by Application (2016-2027)
10.3.3.1. Market Revenue Forecast (2016-2027)
10.3.4.1. Market Revenue Forecast (2016-2027)
10.3.5.1. Market Revenue Forecast (2016-2027)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2016-2027)
10.4.1. Market Revenue Forecast by Product (2016-2027)
10.4.2. Market Revenue Forecast by Application (2016-2027)
10.4.3.1. Market Revenue Forecast (2016-2027)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2016-2027)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Product (2016-2027)
10.5.2. Market Revenue Forecast by Application (2016-2027)
10.5.3.1. Market Revenue Forecast (2016-2027)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2016-2027)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2016-2027)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2016-2027)
Chapter 11. Company Profiles
11.1. Integra LifeSciences Corporation
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
188.8.131.52. ProductDetails, Specification, Application
11.1.3. Revenue, Price, and Gross Margin (2015-2020)
11.1.4. Recent Developments and Strategies
11.2. Aspect Biosystems
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
184.108.40.206. Product Details, Specification, Application
11.2.3. Revenue, Price, and Gross Margin (2015-2020)
11.2.4. Recent Developments and Strategies
11.3. Amgen, Inc.
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
220.127.116.11. Product Details, Specification, Application
11.3.3. Revenue, Price, and Gross Margin (2015-2020)
11.3.4. Recent Developments and Strategies
11.4. Medtronic plc
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
18.104.22.168. Product Details, Specification, Application
11.4.3. Revenue, Price, and Gross Margin (2015-2020)
11.4.4. Recent Developments and Strategies
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
22.214.171.124. Product Details, Specification, Application
11.5.3. Revenue, Price, and Gross Margin (2015-2020)
11.5.4. Recent Developments and Strategies
11.6. Novartis AG
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
126.96.36.199. Product Details, Specification, Application
11.6.3. Revenue, Price, and Gross Margin (2015-2020)
11.6.4. Recent Developments and Strategies
11.7. Smith & Nephew plc
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
188.8.131.52. Product Details, Specification, Application
11.7.3. Revenue, Price, and Gross Margin (2015-2020)
11.7.4. Recent Developments and Strategies
11.8. MiMedx Group
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
184.108.40.206. Product Details, Specification, Application
11.8.3. Revenue, Price, and Gross Margin (2015-2020)
11.8.4. Recent Developments and Strategies
11.9. Shenzhen SibionoGeneTech Co., Ltd.
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
220.127.116.11. Product Details, Specification, Application
11.9.3. Revenue, Price, and Gross Margin (2015-2020)
11.9.4. Recent Developments and Strategies
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
18.104.22.168. Product Details, Specification, Application
11.10.3. Revenue, Price, and Gross Margin (2015-2020)
11.10.4. Recent Developments and Strategies
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Purchase This Premium Research Report @ https://www.precedenceresearch.com/checkout/1176
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defence, among different ventures, present globally.
Call: +1 9197 992 333